300 related articles for article (PubMed ID: 17530504)
1. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
[TBL] [Abstract][Full Text] [Related]
2. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?
Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G
Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
[TBL] [Abstract][Full Text] [Related]
4. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study.
Menezes AM; Perez-Padilla R; Hallal PC; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuze J; Montes de Oca M; Tálamo C;
Int J Tuberc Lung Dis; 2008 Jul; 12(7):709-12. PubMed ID: 18544192
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
6. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
7. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
[TBL] [Abstract][Full Text] [Related]
8. Use of respiratory medication in five Latin American cities: The PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Lopez MV; Muiño A; Jardim JR; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Pulm Pharmacol Ther; 2008 Oct; 21(5):788-93. PubMed ID: 18621136
[TBL] [Abstract][Full Text] [Related]
9. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
Walker PP; Calverley PM
COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
[TBL] [Abstract][Full Text] [Related]
10. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
[TBL] [Abstract][Full Text] [Related]
11. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of airflow obstruction in an elderly Chinese population.
Ko FW; Woo J; Tam W; Lai CK; Ngai J; Kwok T; Hui DS
Eur Respir J; 2008 Dec; 32(6):1472-8. PubMed ID: 18684847
[TBL] [Abstract][Full Text] [Related]
13. COPD 'diagnosis' based on spirometric reference equations.
Olofson J; Bake B; Tengelin MN; Houltz B
Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
[TBL] [Abstract][Full Text] [Related]
14. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
Sposato B; Mariotta S; Ricci A
J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America.
Menezes AM; Hallal PC; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Montes de Oca M; Talamo C; Pertuze J; Victora CG;
Eur Respir J; 2007 Dec; 30(6):1180-5. PubMed ID: 17804445
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
[TBL] [Abstract][Full Text] [Related]
17. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
18. Significant bronchodilator responsiveness and "reversibility" in a population sample.
Prentice HA; Mannino DM; Caldwell GG; Bush HM
COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
[TBL] [Abstract][Full Text] [Related]
19. Acute bronchodilator responsiveness in subjects with and without airflow obstruction in five Latin American cities: the PLATINO study.
Montes de Oca M; Perez-Padilla R; Tálamo C; Halbert RJ; Moreno D; Lopez MV; Muiño A; José Roberto BJ; Valdivia G; Pertuzé J; Ana Maria BM;
Pulm Pharmacol Ther; 2010 Feb; 23(1):29-35. PubMed ID: 19818867
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
